Contact the Editorial Desk

Editorial correspondence

This desk welcomes notes on the record itself: a citation quoted imprecisely, a study whose findings were misread, a regulatory update (an FDA action, a status change for a precursor) that shifts what a page should say, or a peer-reviewed study on NAD+, MOTS-c or Epitalon that belongs on the references page. A correction that makes a page more accurate is the most useful message this desk receives.

The notes easiest to act on name three things: which page, the exact passage in question, and the supporting source — a DOI or PubMed identifier wherever you have one. In that shape, a proposed change can be checked against its source before anything is revised.

Editorial mailbox: editors@newagepeptide.com

Beyond this desk's reach

So no message goes unanswered for the wrong reason, a few requests sit past what this site can do. Because New Age Peptide reports the literature rather than practicing medicine or selling anything, it cannot:

• Weigh in on, endorse, or advise human use of NAD+, MOTS-c, Epitalon, or any related compound.
• Name a dose, schedule, or route for any individual.
• Judge whether a finding from a cited study applies to a specific person's situation.
• Sell, source, or help track down any compound from any supplier.
• Comment on a specific vendor's product quality or purity.
• Guide athletes on anti-doping questions, since MOTS-c specifically carries a prohibited-substance status in some sport contexts.

Anyone seeking guidance on using any of these compounds should take that question to a licensed clinician in their own jurisdiction. Replies aren't guaranteed and can lag; the mailbox is checked periodically.